[
  {
    "ts": "2025-10-26T14:19:41+00:00",
    "headline": "More Rate Cuts Are Coming: Grab 6% High-Yield S&P 500 Stocks Now",
    "summary": "Five of the highest-yielding S&P 500 stocks offer incredible, dependable yields from quality blue-chip companies you can buy and hold forever.",
    "url": "https://247wallst.com/investing/2025/10/26/more-rate-cuts-are-coming-grab-6-high-yield-sp-500-stocks-now/",
    "source": "24/7 Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "873d2898-a943-3ffa-b846-a87e177ad993",
      "content": {
        "id": "873d2898-a943-3ffa-b846-a87e177ad993",
        "contentType": "STORY",
        "title": "More Rate Cuts Are Coming: Grab 6% High-Yield S&P 500 Stocks Now",
        "description": "",
        "summary": "Five of the highest-yielding S&P 500 stocks offer incredible, dependable yields from quality blue-chip companies you can buy and hold forever.",
        "pubDate": "2025-10-26T14:19:41Z",
        "displayTime": "2025-10-26T14:19:41Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/24_7_wall_st__718/81149457a177faba6d598b5c050d2b5b",
          "originalWidth": 1500,
          "originalHeight": 718,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_Cc6LMg3LdMtXqkvweYWiA--~B/aD03MTg7dz0xNTAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/24_7_wall_st__718/81149457a177faba6d598b5c050d2b5b.cf.webp",
              "width": 1500,
              "height": 718,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/GUajlE3Ti1NG2E0eFl8Uyg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/24_7_wall_st__718/81149457a177faba6d598b5c050d2b5b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "24/7 Wall St.",
          "url": "https://247wallst.com/"
        },
        "canonicalUrl": {
          "url": "https://247wallst.com/investing/2025/10/26/more-rate-cuts-are-coming-grab-6-high-yield-sp-500-stocks-now/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/more-rate-cuts-coming-grab-141941677.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ARE"
            },
            {
              "symbol": "VZ"
            },
            {
              "symbol": "MO"
            },
            {
              "symbol": "UPS"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "^SPX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-26T11:25:09+00:00",
    "headline": "Pfizer Inc. (PFE) and Astellas Pharma Announce Survival Results from Phase 3 EMBARK Study",
    "summary": "​Pfizer Inc. (NYSE:PFE) is one of the Most Undervalued Long Term Stocks to Buy Right Now. On October 19, Pfizer Inc. (NYSE:PFE) and Astellas Pharma US Inc. announced final overall survival results from their Phase 3 EMBARK study. ​The study evaluated XTANDI in combination with leuprolide as a monotherapy for men with non-metastatic hormone-sensitive prostate […]",
    "url": "https://finance.yahoo.com/news/pfizer-inc-pfe-astellas-pharma-112509464.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "25368f4a-9db3-32ce-97a1-d13b0fc8ba46",
      "content": {
        "id": "25368f4a-9db3-32ce-97a1-d13b0fc8ba46",
        "contentType": "STORY",
        "title": "Pfizer Inc. (PFE) and Astellas Pharma Announce Survival Results from Phase 3 EMBARK Study",
        "description": "",
        "summary": "​Pfizer Inc. (NYSE:PFE) is one of the Most Undervalued Long Term Stocks to Buy Right Now. On October 19, Pfizer Inc. (NYSE:PFE) and Astellas Pharma US Inc. announced final overall survival results from their Phase 3 EMBARK study. ​The study evaluated XTANDI in combination with leuprolide as a monotherapy for men with non-metastatic hormone-sensitive prostate […]",
        "pubDate": "2025-10-26T11:25:09Z",
        "displayTime": "2025-10-26T11:25:09Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/aef4b35e5ea946bf7f4ed347e5c4f487",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/UKiv8LHLxutAA7dDIzr_pw--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/aef4b35e5ea946bf7f4ed347e5c4f487.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1v0rnd.QZj0de1gLzaNuAg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/aef4b35e5ea946bf7f4ed347e5c4f487.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-inc-pfe-astellas-pharma-112509464.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-inc-pfe-astellas-pharma-112509464.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "4503.T"
            },
            {
              "symbol": "ONPH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-26T08:00:00+00:00",
    "headline": "Got $1,000? 3 High-Yield Healthcare Stocks to Buy and Hold Forever.",
    "summary": "Looking at high-yield healthcare stocks? These three stand out (but one has a slight skew to its story).",
    "url": "https://www.fool.com/investing/2025/10/26/got-1000-high-yield-healthcare-stocks-to-buy-hold/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "9c5382a9-d41f-3998-987d-faf430f202be",
      "content": {
        "id": "9c5382a9-d41f-3998-987d-faf430f202be",
        "contentType": "STORY",
        "title": "Got $1,000? 3 High-Yield Healthcare Stocks to Buy and Hold Forever.",
        "description": "",
        "summary": "Looking at high-yield healthcare stocks? These three stand out (but one has a slight skew to its story).",
        "pubDate": "2025-10-26T08:00:00Z",
        "displayTime": "2025-10-26T08:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/353f8e598764440f637c878ad3c4e609",
          "originalWidth": 1199,
          "originalHeight": 797,
          "caption": "Three people standing on boxes in a desert looking through telescopes.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QLOT3TOXD68OCo8TUeBAeA--~B/aD03OTc7dz0xMTk5O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/353f8e598764440f637c878ad3c4e609.cf.webp",
              "width": 1199,
              "height": 797,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OG0usalStCRlQ0AS1oUJUg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/353f8e598764440f637c878ad3c4e609.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/10/26/got-1000-high-yield-healthcare-stocks-to-buy-hold/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/got-1-000-3-high-080000416.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "KVUE"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MDT"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "^SPX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]